New Approaches to the Pharmacological Treatment of Anxiety and Depression
Reference82 articles.
1. Akindele, M. O., Evans, J. I., & Oswald, I. (1970). Monoamine oxidase inhibitors, sleep and mood. Electroencephalogram and Clinical Neurophysiology, 29, 47–56. 2. Asberg, M., Bertilsson, K., & Tuck, D. (1972). Indolamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline. Clinical and Pharmacological Therapy, 14, 277–286. 3. Asberg, M., Thoren, P., & Traskman, L. (1976). Serotonin depression: A biochemical subgroup within the affective disorders? Science, 191, 478–480. 4. Belmaker, R. H. (1981). Receptors, adenylate cyclase, depression, and lithium. Biological Psychiatry, 16, 333–350. 5. Bond, A. J., & Lader, M. H. (1981). Comparative effects of diazepam and buspirone on subjective feelings, psychological tests and the EEG. International Pharmacopsychiatry, 16, 212–220.
|
|